PhaseBio Pharmaceuticals Shareholders Equity per Share

Shareholders Equity per Share of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity per Share growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity per Share for the quarter ending March 31, 2022 was -2.11 (a 8.92% increase compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity per Share increased by 426.88%
  • Annual Shareholders Equity per Share for 2021 was -2.12 (a 144.21% increase from previous year)
  • Annual Shareholders Equity per Share for 2020 was -0.87 (a -139.76% decrease from previous year)
  • Annual Shareholders Equity per Share for 2019 was 2.18 (a -77.28% decrease from previous year)
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity per Share of PhaseBio Pharmaceuticals

Most recent Shareholders Equity per Shareof PHAS including historical data for past 10 years.

Interactive Chart of Shareholders Equity per Share of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Shareholders Equity per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -2.11
2021 -1.93 -1.05 -0.4 0.27 -2.12
2020 -0.87 0.15 0.92 1.86 -0.87
2019 2.18 2.47 2.92 1.8 2.18
2018 9.6 12.48 0.0 0.0 9.6
2017 0.0 -0.31
2016 0.09

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology